Ivashkin V - Search Results

1

Gut dysbiosis and body composition in cirrhosis.

Maslennikov R, Ivashkin V, Alieva A, Poluektova E, Kudryavtseva A, Krasnov G, Zharkova M, Zharikov Y. Maslennikov R, et al. Among authors: ivashkin v. World J Hepatol. 2022 Jun 27;14(6):1210-1225. doi: 10.4254/wjh.v14.i6.1210. World J Hepatol. 2022. PMID: 35978666 Free PMC article.

2

Cholesteryl Ester Crystals in Lysosomal Acid Lipase Deficiency.

Ivashkin V, Zharkova M. Ivashkin V, et al. N Engl J Med. 2017 Mar 2;376(9):e14. doi: 10.1056/NEJMicm1610060. N Engl J Med. 2017. PMID: 28249129 Free article. No abstract available.

3

Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Maslennikov R, Pavlov C, Ivashkin V. Maslennikov R, et al. Among authors: ivashkin v. Hepatol Int. 2018 Nov;12(6):567-576. doi: 10.1007/s12072-018-9898-2. Epub 2018 Oct 4. Hepatol Int. 2018. PMID: 30284684

4

NT-proBNP as a biomarker for hyperdynamic circulation in decompensated cirrhosis.

Maslennikov R, Driga A, Ivashkin K, Ivashkin V. Maslennikov R, et al. Among authors: ivashkin k, ivashkin v. Gastroenterol Hepatol Bed Bench. 2018 Fall;11(4):325-332. Gastroenterol Hepatol Bed Bench. 2018. PMID: 30425812 Free PMC article.

5

Clinical validation of the "7 × 7" questionnaire for patients with functional gastrointestinal disorders.

Ivashkin V, Sheptulin A, Shifrin O, Poluektova E, Pavlov C, Ivashkin K, Drozdova A, Lyashenko O, Korolev A. Ivashkin V, et al. Among authors: ivashkin k. J Gastroenterol Hepatol. 2019 Jun;34(6):1042-1048. doi: 10.1111/jgh.14546. Epub 2018 Dec 25. J Gastroenterol Hepatol. 2019. PMID: 30462850

6

Differential diagnosis of ascites in internal medicine: clinical case.

Tikhonov IN, Zharkova MS, Maevskaya MV, Zozulya VN, Nekrasova TP, Arslanyan MG, Musina NP, Tatarkina MA, Rzaev RT, Puzakov KB, Ivashkin VT, Malikova MS. Tikhonov IN, et al. Among authors: ivashkin vt. Ter Arkh. 2018 Aug 27;90(8):74-80. doi: 10.26442/terarkh201890874-80. Ter Arkh. 2018. PMID: 30701950

7

[Myocardial Contractile Function in Patients with Liver Cirrhosis and Syndrome of Bacterial Overgrowth Syndrome].

Ivashkin KV, Shirokova EN, Ivashkin VT, Plyusnin SV, Zharkova MS, Maslennikov RV, Skhirtladze MR, Maevskaya MV. Ivashkin KV, et al. Among authors: ivashkin vt. Kardiologiia. 2019 Apr 17;59(4):67-73. doi: 10.18087/cardio.2019.4.10252. Kardiologiia. 2019. PMID: 31002042 Russian.

8

Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Maslennikov R, Pavlov C, Ivashkin V. Maslennikov R, et al. Among authors: ivashkin v. Turk J Gastroenterol. 2019 Nov;30(11):964-975. doi: 10.5152/tjg.2019.18551. Turk J Gastroenterol. 2019. PMID: 31767551 Free PMC article.

9

Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.

Ivashkin VT, Poluektova EA, Glazunov AB, Putilovskiy MA, Epstein OI. Ivashkin VT, et al. BMC Gastroenterol. 2019 Dec 31;20(1):2. doi: 10.1186/s12876-019-1143-5. BMC Gastroenterol. 2019. PMID: 31892312 Free PMC article.

10

The Evolution of Human Probiotics: Challenges and Prospects.

Trush EA, Poluektova EA, Beniashvilli AG, Shifrin OS, Poluektov YM, Ivashkin VT. Trush EA, et al. Probiotics Antimicrob Proteins. 2020 Dec;12(4):1291-1299. doi: 10.1007/s12602-019-09628-4. Probiotics Antimicrob Proteins. 2020. PMID: 31907861 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page